1. Raxibacumab for the treatment of inhalational anthrax
- Author
-
Migone, Thi-Sau, Subramanian, G. Mani, Zhong, John, Healey, Letha M., Corey, Al, Devalaraja, Matt, Lo, Larry, Ullrich, Stephen, Zimmerman, Janelle, Chen, Andrew, Lewis, Maggie, Meister, Gabriel, Gillum, Karen, Sanford, Daniel, Mott, Jason, and Bolmer, Sally D.
- Subjects
Anthrax -- Drug therapy ,Anthrax -- Prognosis ,Immunoglobulin G -- Evaluation ,Monkeys -- Diseases ,Monkeys -- Care and treatment ,Rabbits -- Care and treatment - Abstract
A study was conducted to determine the effectiveness of raxibacumab for the treatment of inhalational anthrax. Results showed that trials carried out on rabbits and monkeys with symptomative inhalational anthrax has better chances of survival following a single dose of raxibacumab.
- Published
- 2009